Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers – 2021 to 2022

$3,850.00$5,850.00

Published on: April 1, 2021
Clear
SKU: GMS-1225 Category:

OVERVIEW

The Breast Cancer Liquid Biopsy Market is expected to reach USD 293.5 million by 2026, growing at a CAGR of 19.2% during the forecast period. Major factors driving the market include rise in demand for safe and non-invasive procedures, advantages of breast cancer liquid biopsy tests over traditional tests, and increase in the global prevalence rate of breast cancer have boosted the growth of the global breast cancer liquid biopsy market. The outbreak of COVID-19 and followed pandemic hampered the growth of the industry across the globe. However, the breast cancer liquid biopsy industry has been affected by COVID-19 to a limited extend, the rise in the COVID-19 infection among healthcare workers has created a short supply for the R&D activities of breast cancer liquid biopsy.

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers – 2021 to 2022 1

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers – 2021 to 2022 2

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers – 2021 to 2022 3

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers – 2021 to 2022 4

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers – 2021 to 2022 5

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers – 2021 to 2022 6

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers – 2021 to 2022 7

Breast Cancer Liquid Biopsy Market by Competitive Landscape (Collaboration, Acquisition, Mergers, Competitive technology), Platform Comparison, Region, End User, Investments, Market Dynamics, Circulating Biomarkers – 2021 to 2022 8

TABLE OF CONTENT

1 Global Breast Cancer Liquid Biopsy Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Breast Cancer Liquid Biopsy Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Breast Cancer Liquid Biopsy Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Breast Cancer Liquid Biopsy Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Breast Cancer Liquid Biopsy Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Breast Cancer Liquid Biopsy Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Breast Cancer Liquid Biopsy Market – By Circulating Biomarker (Market Size – &
million/billion)
8.1 Circulating Tumor Cells (CTCs)
8.2 Cell-free DNA (cfDNA)
8.3 Extracellular Vesicles (EVs)
8.4 Other

9 Global Breast Cancer Liquid Biopsy Market – By End-User
9.1 Reference Laboratories
9.2 Hospitals and Physician Laboratories
9.3 Other

10 Global Breast Cancer Liquid Biopsy Market – By Geography (Market Size – &
million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 Global Breast Cancer Liquid Biopsy Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 Global Breast Cancer Liquid Biopsy Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Company 1
12.3 Company 2
12.4 Company 3
12.5 Company 4
12.6 Company 5
12.7 Company 6
12.8 Company 7
12.9 Company 8
12.10 Company 9
12.11 Company 10
12.12 Company 11 & more

13 Global Breast Cancer Liquid Biopsy Market – Appendix
13.1 Sources
13.2 Abbreviations